A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1999
12/08/1999	CN1237432A Chinese medicine chive buld composite for improving hyperlipemia
12/07/1999	US5998615 Alzheimer's disease; nervous system disorders
12/07/1999	US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999	US5998400 Atherosclerosis
12/07/1999	US5997915 Natural isomers of tetrahydrofolic acid derivatives
12/07/1999	US5997848 Methods and compositions for pulmonary delivery of insulin
12/07/1999	CA2211522C Novel compounds
12/07/1999	CA2180717C Use of phosphorus derivatives of alkaloids for treating endocrinopathies
12/07/1999	CA2015515C Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
12/07/1999	CA2013037C Aminobenzenesulfonic acid derivative
12/02/1999	WO1999061645A1 Novel compound, wf00144
12/02/1999	WO1999061626A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999	WO1999061602A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999	WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061435A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
12/02/1999	WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999	WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999	WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999	WO1999061410A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999	WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	WO1999061038A1 Composition having therapeutic and/or nutritionally active substituent
12/02/1999	WO1999061037A1 Plant material composition
12/02/1999	WO1999061036A1 Use of arabinoxylans for preparing a composition
12/02/1999	WO1999061035A1 Preparation based on the artichoke plant, especially for use as a medicament or food supplement
12/02/1999	WO1999061023A1 Cocaine receptor binding ligands
12/02/1999	WO1999061004A1 Controlled release lipoic acid
12/02/1999	WO1999060869A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
12/02/1999	WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999	WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999	DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999	CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	CA2333157A1 Novel substituted imidazole compounds
12/02/1999	CA2332617A1 Use of arabinoxylans for preparing a composition
12/02/1999	CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	CA2331056A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999	CA2330620A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
12/02/1999	CA2329159A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products
12/02/1999	CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999	CA2329072A1 Human transmembrane proteins
12/01/1999	EP0960883A1 Substituted thiazolidinedione derivatives
12/01/1999	EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999	EP0960567A2 Fat based food products
12/01/1999	EP0960335A2 Modulators of insulin receptor activity
12/01/1999	EP0960141A1 Cross-linked vinyl polymers with bile acid adsorbing effect
12/01/1999	EP0959886A1 Triaryl substituted imidazoles as glucagon antagonists
12/01/1999	EP0959885A1 Triaryl substituted imidazoles and methods of use
12/01/1999	CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives
12/01/1999	CN1237177A Fused bicyclic pyrimidine derivatives
12/01/1999	CN1237160A Process for preparing substituted pyridines
12/01/1999	CN1236613A Medicinal composition for preventing and curing hypokalemia.
11/1999
11/30/1999	US5994569 Useful in the treatment or prevention of vitamin d dependent disorders and of il-12-dependent autoimmune diseases
11/30/1999	US5994500 Antagonists of intestinotrophic GLP-2 peptides
11/30/1999	US5994404 Nervonic acid compositions
11/30/1999	US5994391 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
11/30/1999	US5994384 Hypersensitization of adrenergic receptors
11/30/1999	US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999	US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999	US5994370 Indene compounds having activity as SERMS
11/30/1999	US5994366 Psychological disorders
11/30/1999	US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999	US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999	US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999	US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999	US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999	US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999	US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5993863 Contains sugars, amino acids, electrolytes and a fat emulsion at a specific mixing ratio and has a specific ph value and a titratable acidity.
11/30/1999	US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993806 Method of stabilizing pharmaceutical preparations comprising digestive enzyme mixtures
11/30/1999	US5993799 Methods of using genetically engineered cells that produce insulin in response to glucose
11/30/1999	CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
11/30/1999	CA2019035C Stabilized radiopharmaceutical compositions
11/30/1999	CA1340836C Mixed compositions for treating hypercholesterolemia
11/25/1999	WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999	WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999	WO1999059997A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
11/25/1999	WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999	WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999	WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999	WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999	WO1999059957A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
11/25/1999	WO1999059617A2 Immunoregulator
11/25/1999	WO1999059607A1 Method of extracting antioxidants from labiate species and the extract products thereof
11/25/1999	WO1999059570A1 Protease inhibitors
11/25/1999	WO1999059564A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism
11/25/1999	WO1999059553A1 Effervescent preparations
11/25/1999	WO1999059549A1 Biodegradable sustained-release alginate gels
11/25/1999	WO1999059526A2 Protease inhibitors
11/25/1999	WO1999059421A1 Esterified and subsequently hydrogenated phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
11/25/1999	WO1999047517A8 Novel heterocyclic compounds

1 ... 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 ... 1298